Tumor-targeting drug delivery of new-generation taxoids

A long-standing problem of conventional cancer chemotherapy is the lack of tumor specificity. Tumor-targeting drug-delivery systems have been explored to overcome this problem. These systems combine a powerful cytotoxic anticancer agent with a tumor-targeting molecule via a 'smart' linker...

Full description

Saved in:

Bibliographic Details
Published in:	Future medicinal chemistry Vol. 4; no. 1; p. 33
Main Authors:	Ojima, Iwao, Zuniga, Edison S, Berger, William T, Seitz, Joshua D
Format:	Journal Article
Language:	English
Published:	England 01-01-2012
Subjects:	Antineoplastic Agents, Phytogenic - administration & dosage Antineoplastic Agents, Phytogenic - therapeutic use Drug Delivery Systems Humans Neoplasms - drug therapy Neoplasms - pathology Taxoids - administration & dosage
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	A long-standing problem of conventional cancer chemotherapy is the lack of tumor specificity. Tumor-targeting drug-delivery systems have been explored to overcome this problem. These systems combine a powerful cytotoxic anticancer agent with a tumor-targeting molecule via a 'smart' linker to form highly efficacious drug conjugates. These drug conjugates can deliver potent cytotoxic drugs specifically to tumors and tumor cells with minimal systemic toxicity. This review describes our groups' research on the molecular approaches to the design and development of a novel drug-delivery system bearing highly potent new-generation taxoids for tumor-targeting chemotherapy in our laboratory.
ISSN:	1756-8927
DOI:	10.4155/FMC.11.167